Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.4 USD | -0.58% | -3.36% | +13.20% |
05-14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
05-06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.20% | 6.57B | |
+42.33% | 50.93B | |
-0.42% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.99% | 26.02B | |
-21.91% | 18.9B | |
+7.54% | 13.21B | |
+24.20% | 12.17B | |
+29.99% | 12.16B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 09